Does CARFILZOMIB Cause Bone marrow failure? 53 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Bone marrow failure have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.2% of all adverse event reports for CARFILZOMIB.
53
Reports of Bone marrow failure with CARFILZOMIB
0.2%
of all CARFILZOMIB reports
18
Deaths
26
Hospitalizations
How Dangerous Is Bone marrow failure From CARFILZOMIB?
Of the 53 reports, 18 (34.0%) resulted in death, 26 (49.1%) required hospitalization, and 14 (26.4%) were considered life-threatening.
Is Bone marrow failure Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 53 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Bone marrow failure?
CYCLOPHOSPHAMIDE (1,834)
METHOTREXATE (1,401)
ETOPOSIDE (1,081)
RITUXIMAB (1,060)
CYTARABINE (1,052)
VINCRISTINE (1,001)
DOXORUBICIN (1,000)
PALBOCICLIB (951)
CARBOPLATIN (855)
BEVACIZUMAB (835)
Which CARFILZOMIB Alternatives Have Lower Bone marrow failure Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL